These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18174683)

  • 1. A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori.
    Nishizawa T; Suzuki H; Masaoka T; Iwasaki E; Hibi T
    Digestion; 2007; 76(3-4):215-20. PubMed ID: 18174683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
    J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
    Fukuda S; Shimoyama T; Tanaka M; Nakasato F; Fukushi M; Munakata A
    Jpn J Infect Dis; 2006 Dec; 59(6):367-9. PubMed ID: 17186954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
    Matsushima M; Suzuki T; Kurumada T; Watanabe S; Watanabe K; Kobayashi K; Deguchi R; Masui A; Takagi A; Shirai T; Muraoka H; Kobayashi I; Mine T
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):232-6. PubMed ID: 16460479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
    Nguyen TV; Bengtsson C; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
    Helicobacter; 2008 Dec; 13(6):550-6. PubMed ID: 19166421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori].
    Sakurai K; Takahashi H; Yamaguchi Y; Yamada M; Kirihara K; Kojima T; Fujita R
    Nihon Rinsho; 1999 Jan; 57(1):72-5. PubMed ID: 10036938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
    Vakil N; Zullo A; Ricci C; Hassan C; Vaira D
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1304-8. PubMed ID: 18774949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful platelet recovery after the second eradication of Helicobacter pylori with metronidazole in two patients with chronic idiopathic thrombocytopenic purpura].
    Takahashi T; Hatao K; Yamada K
    Rinsho Ketsueki; 2006 May; 47(5):392-5. PubMed ID: 16784096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
    Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
    J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
    Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
    J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection?
    Cremonini F; Bartolozzi F; Armuzzi A; Zocco MA; Santarelli L; Gabrielli M; Candelli M; Nista EC; Santoliquido A; Gasbarrini A
    Hepatogastroenterology; 2005; 52(64):1119-21. PubMed ID: 16001643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
    Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
    Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
    Cai W; Zhou L; Ren W; Deng L; Yu M
    Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the relationship between Helicobacter pylori microbial susceptibility, 13C-urea breath test values.
    Kawai T; Kawakami K; Kataoka M; Itoi T; Takei K; Moriyasu F; Takagi Y; Aoki T; Serizawa H; Rimbard E; Noguchi N; Sasatsu M
    Hepatogastroenterology; 2008; 55(82-83):786-90. PubMed ID: 18613455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis.
    Severi C; Abdullahi M; Tari R; Vannella L; Marcheggiano A; Capoccia D; Leonetti F; Osborn J; Annibale B
    Dig Liver Dis; 2009 Aug; 41(8):555-8. PubMed ID: 19179127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.